PHENOTYPE LOCK

Serial Number 97388990
731

Registration Progress

Application Filed
Apr 29, 2022
Under Examination
May 14, 2024
Approved for Publication
Feb 28, 2024
Published for Opposition
Mar 19, 2024
Registered

Attorney Assistance

Statement of Use Due - Extension 2 Granted
Due: Nov 14, 2025 104 days

Trademark Image

PHENOTYPE LOCK

Basic Information

Serial Number
97388990
Filing Date
April 29, 2022
Published for Opposition
March 19, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
731
Status Date
Mar 21, 2025
Application
Pending
Classes
001 005 040

Rights Holder

Quell Therapeutics Limited

99
Address
3rd Floor, Translation & Innovation Hub
84 Wood Lane
London W120BZ
GB

Ownership History

Quell Therapeutics Limited

Original Applicant
99
London GB

Quell Therapeutics Limited

Owner at Publication
99
London GB

Legal Representation

Attorney
Carlynn Beth Ferguson

USPTO Deadlines

Next Deadline
104 days remaining
Statement of Use Due - Extension 2 Granted
Due Date
November 14, 2025
Extension Available
Until May 14, 2025

Application History

45 events
Date Code Type Description Documents
Mar 22, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 21, 2025 EX2G S SOU EXTENSION 2 GRANTED Loading...
Mar 21, 2025 EXT2 S SOU EXTENSION 2 FILED Loading...
Mar 21, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 13, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 5, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Jun 5, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jun 5, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 14, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 19, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 19, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 28, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 28, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 15, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 15, 2024 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Feb 15, 2024 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Feb 15, 2024 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Feb 15, 2024 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Nov 1, 2023 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Nov 1, 2023 GNFR O FINAL REFUSAL E-MAILED Loading...
Nov 1, 2023 CNFR R FINAL REFUSAL WRITTEN Loading...
Nov 1, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 31, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 31, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 15, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 15, 2023 GNRT O NON-FINAL ACTION E-MAILED Loading...
Aug 15, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 21, 2023 ZZZX Z PREVIOUS ALLOWANCE COUNT WITHDRAWN Loading...
Jul 11, 2023 PBCR Z WITHDRAWN FROM PUB - OG REVIEW QUERY Loading...
Jun 29, 2023 FIXD O ELECTRONIC RECORD REVIEW COMPLETE Loading...
Jun 23, 2023 ERRR O ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED Loading...
Jun 22, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 22, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jun 22, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jun 22, 2023 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Jun 22, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
May 20, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 19, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 19, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Feb 27, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Feb 27, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Feb 27, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 16, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
May 4, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 3, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
Chemical and biological preparations for use in science and industry; Chemical and biological preparations for genetically modifying human and animal cells for non-medical purposes; reagents for use in the genetic modification of human and animal cells for scientific or medical research use; human and animal cells and parts in the nature of stem cells thereof for scientific and research purposes; T cells for scientific and research purposes; regulatory T cells for scientific and research purposes; preparations of blood or cells extracted from humans and animals for scientific and research purposes; chimeric antigen receptors and preparations thereof for scientific and research purposes; antibody reagents used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use for use in science and industry; nucleic acids for laboratory use; synthetic deoxyribonucleic acids for scientific purposes; viral vectors for use in science and industry; nucleic acid vectors for use in science and industry
Class 005
Pharmaceutical and biological preparations for diagnostic, medical, therapeutic and prophylactic use, namely for the treatment of genetic, autoimmune and inflammatory diseases, disorders and deficiencies, and for preventing organ transplant rejection; pharmaceutical, medical and veterinary preparations for diagnostic, therapeutic and prophylactic purposes, namely for the treatment of genetic, autoimmune and inflammatory diseases, disorders and deficiencies, and for preventing organ transplant rejection; pharmaceutical preparations for cell therapy; pharmaceutical preparations for gene therapy; pharmaceutical preparations for genetically modifying human and animal cells for diagnostic and medical purposes; human and animal cells and parts, namely stem cells thereof for medical and veterinary purposes; T cells for medical and veterinary purposes; regulatory T cells for medical and veterinary purposes; preparations of blood or cells extracted from humans and animals which have been adapted for therapeutic purposes; pharmaceutical, medical and clinical preparations for use in treatment, amelioration and prophylaxis of diseases, disorders and suppression of the immune system; immunological agents and preparations for medical purposes, namely for the treatment of genetic, autoimmune and inflammatory diseases, disorders and deficiencies, and for preventing organ transplant rejection; pharmaceutical preparations for therapies to modulate the immune system; pharmaceutical preparations for therapies for autoimmune conditions and immunological disorders; chimeric antigen receptors and therapeutic preparations for the treatment of genetic, autoimmune and inflammatory diseases, disorders and deficiencies, and for preventing organ transplant rejection; pharmaceutical preparations for therapeutic delivery of nucleic acids; viral vectors for therapeutic and prophylactic purposes for the treatment of genetic, autoimmune and inflammatory diseases, disorders and deficiencies, and for preventing organ transplant rejection; nucleic acid vectors for therapeutic and prophylactic purposes for the treatment of genetic, autoimmune and inflammatory diseases, disorders and deficiencies, and for preventing organ transplant rejection; medical pharmaceutical preparations containing viral vectors for therapeutic and prophylactic purposes for the treatment of genetic, autoimmune and inflammatory diseases, disorders and deficiencies, and for preventing organ transplant rejection; medical preparations containing nucleic acid vectors for therapeutic and prophylactic purposes for the treatment of genetic, autoimmune and inflammatory diseases, disorders and deficiencies, and for preventing organ transplant rejection
Class 040
Pharmaceutical manufacturing and processing; biological, biotechnological and biopharmaceutical manufacturing and manufacturing processing; manufacturing processing of biological tissue, blood, cell and genetic material; viral vector production, namely manufacture; gene therapy production, namely manufacture; custom manufacture of pharmaceutical and biological formulations and products; processing and modification of human and animal cells in the custom manufacture of pharmaceutical and biological formulations and products

Classification

International Classes
001 005 040